WHO, African Agency Partner on Medicine Access

Why this is here: The agreement focuses on streamlining regulatory processes to enable faster approval of medical products across Africa, potentially reducing costs for both patients and manufacturers.

The World Health Organization and the African Medicines Agency signed a collaboration agreement in Geneva, Switzerland. This partnership intends to strengthen regulatory systems and improve access to safe medicines across Africa. The agreement builds on a previous understanding between the African Union and WHO from May 2025, and outlines joint plans for the next three to five years.

Fragmented regulations, limited manufacturing, and substandard products currently hinder medicine access on the continent. The WHO and AMA will prioritize regulatory harmonization, safety surveillance, and workforce development. They also aim to streamline approval processes and encourage local production to lower costs and improve efficiency.

A key goal is establishing a unified regulatory system, though full implementation depends on member state ratification of the AMA treaty and sustained financial investment. The agencies envision the AMA becoming a model for regional cooperation, potentially influencing global health security. The work to build a stronger, more reliable system continues.